-
This Evidently Cochrane blog (originally posted here) is for all those involved in clinical trials. Katie Gillies and Derek Stewart, from the Trials Methodology Research Partnership and the Health Research Board Trials Methodology Research Network, highlight the need for focussed research on trial retention to help fill the evidence gaps...
19 May 2021
-
18 May 2021
-
18 May 2021
-
Cochrane, together with a range of other civil society organisations, has written to a group of medicines agencies in Europe asking that they take action to ensure trial transparency.
Despite an EU legislation requiring that results from clinical trials be published on the EU Clinical Trials Register within 12 months of a study ending, this...
10 May 2021
-
Updated review: Can international travel-related control measures contain the spread of the COVID-19 pandemic?
May 10: updated with visual abstract
What are international travel-related control measures?
International travel control measures are methods to manage international travel to contain the spread of COVID-19. Measures include:
closing...
10 May 2021
-
The World Health Organization (WHO) and International Coalition of Medicines Regulatory Authorities (ICMRA) have issued a joint statement calling on the pharmaceutical industry to increase transparency and access to clinical data for all new medicines and vaccines.
Dr Karla Soares-Weiser, Editor in Chief of The Cochrane Library and Acting CEO of...
7 May 2021
-
In this recently published Cochrane review, the author team explored whether taking a certain type of medication could make older people more likely to develop dementia.
Discussing the review, Terry Quinn, senior author, said: "Almost every week we see a newspaper headline describing something new that allegedly causes or protects against...
5 May 2021
-
In this author interview, lead authors Nick Meader and Andrew Moriarity tell us about this recently published Cochrane review, how they worked with a patient advisory group, and how they rose to the challenge of this being their first prognostic review, and the first of this type for Cochrane Common Mental Disorders.
Nick Meader: According to the...
5 May 2021
-
A recently published review from Cochrane Effective Practice and Organisation of Care (EPOC) Group looks at the effects of ‘pay for performance’ on the delivery of healthcare services in low- and middle-income countries.
Karin Diaconu, first author of this review, notes, "There is growing interest in paying for performance as an approach for...
5 May 2021
-
New Cochrane Review on the efficacy and safety of inhalers for those with mild asthma published on World Asthma Day.
World Asthma Day on 5 May is an annual event on organized by the Global Initiative for Asthma (GINA) to improve asthma awareness and care around the world.
Cochrane Airways works with authors (typically clinicians and researchers)...
4 May 2021
-
23 April 2021
-
23 April 2021
-
Antidepressants are widely used for depression and anxiety. Guidelines recommend that an antidepressant should be continued for at least six months after people start to feel better, and for at least two years if they have had two or more periods of depression. Many people take antidepressants for much longer. Ellen Van Leeuwen and Mark Horowitz,...
22 April 2021
-
Dear Community Colleagues,
Last week, we informed you of the news that Mark Wilson was stepping down from his role as Chief Executive Officer (CEO) after eight years of outstanding service.
Today, we want to provide you with an update of the Governing Board's plans during this transition period for organizational leadership.
Our Editor in Chief...
21 April 2021
-
20 April 2021
-
Wednesday 7 April marks World Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to spotlight health equity.
Health equity is the absence of avoidable and unfair differences in health. The COVID-19 pandemic and its uneven impacts worldwide has brought attention to...
7 April 2021
-
Cochrane community contributes to update to the PRISMA statement. PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA primarily focuses on the reporting of reviews evaluating the effects of interventions, but can also be used as a basis for reporting systematic reviews with objectives...
7 April 2021
-
Interview with Heather Tubwon, the artist that created the new limited edition designs in the Cochrane store celebrating Anne Anderson and our diverse community.
The global Cochrane community are participating in a virtual walk and raising money for the annual Anne Anderson Award, which is given to a Cochrane member who has contributed...
6 April 2021
-
In March 2020, Cochrane Australia convened the National COVID-19 Clinical Evidence Taskforce - bringing together leading health researchers, experts and organisations from across the country.
Since then, over 240 members have worked around the clock to deliver living clinical guidelines and flowcharts for frontline health workers. The...
1 April 2021
-
Cochrane provides high-quality, relevant and up-to-date synthesized research evidence to inform health decisions. This page highlights the many ways that Cochrane has successfully responded to COVID-19 around the world. Click on any of the case studies below to find out more, and check back often as we continuously add and update new stories....
1 April 2021